<DOC>
	<DOCNO>NCT02592486</DOCNO>
	<brief_summary>The immunogenicity simultaneous administration quadrivalent influenza vaccine pneumococcal vaccine unknown . The purpose present study compare immunogenicity simultaneous administration influenza vaccine pneumococcal vaccine separate administration .</brief_summary>
	<brief_title>The Immunogenicity Simultaneous Administration Quadrivalent Influenza Vaccine 23-valent Pneumococcal Vaccine</brief_title>
	<detailed_description>The immunogenicity simultaneous administration quadrivalent influenza vaccine pneumococcal vaccine unknown . We compare immunogenicity simultaneous administration quadrivalent influenza vaccine pneumococcal vaccine separate administration . 162 Participants randomly assign one two study group ; Simultaneous administration group : receive injection pneumococcal vaccine influenza vaccine simultaneously . Sequential administration group : receive injection pneumococcal vaccine 2 week injection influenza vaccine . We compare immunogenicity two group .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>adult age â‰§65 year never receive pneumococcal vaccine quadrivalent influenza vaccine 2015/2016 season sensitivity pneumococcal influenza vaccine receive inactivated vaccine within 14 day receive live vaccine within 28 day presence condition know impair pneumococcal vaccine response malignant disease take oral corticosteroid immunosuppressive agent history splenectomy history acute febrile illness sign severe acute illness time vaccination inappropriate condition receive vaccination suffer acute illness require antibiotic steroid within past month expect survive 12 month also exclude</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>quadrivalent influenza vaccine</keyword>
	<keyword>23-valent pneumococcal vaccine</keyword>
	<keyword>immunogenicity</keyword>
</DOC>